Meconium aspiration is a severe neonatal respiratory disorder frequently complicated by pulmonary hypertension. To evaluate the role of endothelin-1(ET-1) and atrial natriuretic peptide (ANP) in this vascular disorder, plasma ET-1and ANP levels were measured serially for 6 hours after meconium instillation in juvenile pigs.
Eleven 10-week-old anesthetized and catheterized pigs received intratracheally a bolus of 3 ml/kg 20% human meconium, five of them were premedicated with 30 mg/kg methylprednisolone. Another six pigs served as saline controls. Ventilator settings were adjusted to avoid systemic hypoxemia and hypercarbia. Meconium aspiration resulted in a biphasic increase in plasma ET-1 level with a significant correlation to pulmonary vascular resistance(PVR) (r=0.72). Methylprednisolone had no effect on the early (0-1 h) ET-1 increase, but prevented significantly the second phase (1-6 h) rise with a concomitant attenuation of the pulmonary hypertensive response. ANP concentration was higher in the meconium than control group and further increased after steroid treatment with a good correlation to ET-1 (r=0.86).
Thus, the development of pulmonary hypertension after meconium aspiration is associated with a simultaneous rise in both ET-1 and ANP levels in plasma. Methylprednisolone pretreatment prevents the progressive elevation of both ET-1 and PVR with marked increase in ANP suggesting that these vasoactive peptides may contribute to the pathophysiology of meconium aspiration associated pulmonary hypertension.
Author information
Authors and Affiliations
Additional information
(Spon by: Olli G. Simell)
Rights and permissions
About this article
Cite this article
Soukka, H., Kääpä, P. Methylprednisolone modulates plasma endothelin-1 and atrial natriuretic peptide levels in meconium aspiration-induced hypertensive lung injury† 1596. Pediatr Res 41 (Suppl 4), 268 (1997). https://doi.org/10.1203/00006450-199704001-01615
Issue Date:
DOI: https://doi.org/10.1203/00006450-199704001-01615